申请人:Proximagen Limited
公开号:US20150005321A1
公开(公告)日:2015-01-01
This invention relates to modulation of the α7 nicotinic acetylcholine receptor (nAChR) by a compound of formula (I):
or a pharmaceutically acceptable salt thereof.
本发明涉及一种通过式(I)化合物或其药学上可接受的盐来调节α7尼古丁乙酰胆碱受体(nAChR)的方法。